Summary
In six patients with primary Sjögren’s syndrome defined with HLA-anti-gens and no clinical signs of pancreatitis, the pancreatic ductal morphology (as described by endoscopic retrograde pancreatography), serum pancreatic enzymes, and fecal fat excretion were examined and secretin test was carried out. Further, oral glucose tolerance test with concomitant determination of serum insulin and C-peptide were done. All patients had at least two pathological signs of exocrine function and/or ductal morphology. There was no evidence of endocrine malfunction. The findings are suggestive of the existence of a clinically silent pancreatitis, perhaps of autoimmune etiology.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sjögren H. Zur Kenntnisder Kerotoconjunctivitissicca. Acta Ophtalmol. 1933; 11: 1–151.
Strand V, Talal N. Advances in the diagnosis and concept of Sjogren’s syndrome (autoimmune exocrinopathy). Bull. Rheumat. DIs. 1979-80; 30: 1046–1052.
Shearn MA. Sjögren’s syndrome. Med. Clin. North. Am. 1977; 61; 1271–1282.
Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Frank MM, Lawley TJ, Hamburger MI. Sjögren’s syndrome (Sicca syndrome): Current issues. Ann. Intern. Med. 1980; 92: 212–225.
Kjellén G, Fransson SG, Lindstrom F, Sékjer H, Tibbling L. Esophageal function and dysphagia in Sjégren’s syndrome. DIg. Dis. Sci. 1986; 31: 225–229.
Maury CPJ, Térnroth T, Teppo AM. Atrophic gastritis in Sjégren’s syndrome. Arthr. Rheum. 1985; 2: 388–394.
Fenster LF, Buchanan WW, Laster M, Bunim JJ. Studies of pancreatic function in Sjégren’s syndrome. Ann. Intern. Med. 1964; 61: 498–508.
Hradsky M, Bartos V, Keller O. Pancreatic function in Sjégren’s syndrome. Gastroenterologia 1967; 108: 252–260.
Dreiling DA, Soto JM. The pancreatic involvement in disseminated “collagen” disorders. Am. J. Gastroenterol. 1976; 66: 546–553.
Magid E, Frost-Larsen K, Isager H, Manthorpe R, Prause JU. Serum isoamylases in Sjégren’s syndrome. Scand. J. Rheumatol. 1983; 12: 129–132.
Daniels TE. Labial salivary gland biopsy in Sjégren’s syndrome. Arthritis Rheum. 1984; 27: 147–156.
Linstrom FD, Hellquist H, Olofsson J. Evaluation of lip salivary gland biopsy in 21 patients with primary Sjégren’s syndrome. Clin. Immunol. Immunopathol. 1987; 45: 156–165.
Jontell M, Ståhlblad P-Å, Rosdahl I, Lindblom B. HLA-DR3 antigens in erosive oral lichen planus, cutaneous lichen planus and lichenoid reactions. Acta Odontol. Scand. 1988; 45: 309–312.
O’Donell MF, Fitzgerald O, McGeeney KF. Differential serum amylase determination by use of an inhibitor, and design of a routine procedure. Clin. Chem. 1977; 23: 560–566.
Ziegenhorn J, Neumann U, Knitsch KW, Zwez W. Determination of serum lipase. Clin. Chem. 1979; 25: 1067.
Gravesen KJ. Fat concentration in feces. Acta Med. Scand. 1964; 175: 271–280.
Rolny P. Diagnosis of pancreatic disease with special reference to the secretin-CCK test. Scand. J. Gastroenterol. 1980; 15 (suppl 60): 1–33.
Oral glucose tolerance test. World Health Organization Technical Report Series 727: Diabetes mellitus. WHO, Geneva, Switzerland, 1985.
Arnquist H, Olsson PO, von Schenck H. Free and total insulin as determined after precipitation with polyethylene glycol: Analytical characteristics and effects of sample handling and storage. Clin. Chem. 1987; 33:93–96.
Nilsson A, von Schenck H. Insulin and C-peptide values during the (WHO) oral glucose tolerance test in normal adults. Acta Endocrinol. 1989; 120 (suppl 2): 47.
Oi I. Fiberduodenoscopy and endoscopic pancreatocholangiography. Gastrointest. En-dosc. 1970; 17: 59–62.
Cotton PB. Cannulation of the papilla of Vater by endoscopy and retrograde cholangiopancreatography (ERCP). Gut 1972; 13: 1014–1025.
Sarner M, Cotton PB. Classification of pancreatitis: International workshop. Gut 1984; 25: 756–759.
Ventrucci M, Pezzilli R, Gullo L, Plate L, Sprovieri G, Barbara L. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig. Dis. Sci. 1989; 34: 39–45.
Tsianos EB, Tzioufas AG, Kita O, Tsolas O, Moutsopoulos HM. Serum isoamylases in patients with autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 1984; 2: 235–238.
Go VLW, DiMagno EP. Assessment of exocrine pancreatic function by duodenal intubation. Clinics in Gastroenterol; 1984; 13: 701–715.
Lankisch PG, Otto J, Arglebe C, Chilla R. Pancreatic function in Sjogren’s syndrome. Letter to the editor.Dig. Dis. Sci. 1988; 33: 1499–1500.
Ludwig H, Schernthaner G, Scherak, O, Kolarz G. Antibodies to pancreatic duct cells in Sjögren’s syndrome and rheumatoid arthritis. Gut 1977; 18: 311–315.
Ellman P, Weher FD, Goodier TEW. A contribution to the pathology of Sjögren’s disease. Quart. J. Med. 1951; 20: 33–42.
Bucher UG, Reid L. Sjögren’s syndrome-report of a fatal case with pulmonary and renal lesions. Br. J. Dis. Chest 1959; 53: 237–252.
Bobo P, Mirakiam R, Merigo, F, Angelini G, Cavallini G, Rizzini P, Bottazzo GF, Scuro LA. HLA molecule expression on chronic pancreatitis specimens: Is there a role for auto-immunity? A preliminary study. Pancreas 1987; 2: 350–352.
Jonsson R, Klareskog L, Bäckman K, Tarkowski A. Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, β2-microglobulin, and interleukin 2 receptor in Sjögren’s syndrome. Clin. Immunol. Immunopathol. 1987; 45: 235–243.
Kreel L, Sandin B. Changes in pancreatic morphology associated with aging. Gut 1973; 14: 962–970.
Schmitz-Moormann P, Himmelmann GW, Brandes J-W, Fölsch UR, Lorenz-Meyer H, Malchow H, Soehendra LN, Wienbeck M. Comparative radiological and morphological study of human pancreas. Pancreatitis like changes in postmortem ductograms and their morphological pattern. Possible implication for ERCP. Gut 1985; 26: 406–414.
Sahel J. Endoscopic retrograde pancreatography findings and their grading in chronic pancreatitis. In: MalfertheinerP and Ditschuneti H, eds., Diagnostic procedures in pancreatic disease. Springer-Verlag Berlin, Heidelberg, 1986, 170–174.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindström, E., Lindstrom, F., Schenck, H.v. et al. Pancreatic ductal morphology and function in primary sjögren’s syndrome. Int J Pancreatol 8, 141–149 (1991). https://doi.org/10.1007/BF02924428
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02924428